Ultragenyx
Price & Volume
Stats
See moreOpen | $29.78 |
Previous Close | $29.69 |
Day Range | $29.61-$29.87 |
52W Range | $25.81-$60.37 |
Market Cap | $2.8B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $610.1M |
Revenue Growth (YoY) | 13.2% |
Gross Profit (12 Mos) | -$167.8M |
Diluted EPS | -$5.48 |
News
See moreYahoo Finance • yesterday
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Yahoo Finance • 5 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Yahoo Finance • 13 days ago
Ultragenyx earnings beat by $0.13, revenue topped estimates
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,294 |
